구연산 칼륨

투여 경로

금기

• Renal failure or severe renal impairment
• Hyperkalemia
• Metabolic alkalosis
• Struvite urolithiasis (requires acidic urine)

이상반응

• Gastrointestinal upset (nausea, vomiting, diarrhea)
• Hyperkalemia (rare if renal function is normal)

약물 상호작용

• Spironolactone · Increased risk of hyperkalemia due to potassium-sparing effects · major
• ACE inhibitors (e.g., Benazepril, Enalapril) · Increased risk of hyperkalemia · moderate
• NSAIDs · May increase the risk of hyperkalemia in compromised patients · minor

모니터링

• Urine pH
• Serum potassium levels
• Renal function (BUN, Creatinine)
• Urinalysis (for crystal formation)

과용량

Overdosage may lead to **hyperkalemia** and **metabolic alkalosis**. Clinical signs of hyperkalemia include muscle weakness, bradycardia, and potentially fatal cardiac arrhythmias. Treatment involves discontinuing the supplement, administering non-potassium containing IV fluids, and potentially using calcium gluconate, dextrose, and insulin in severe cases.